- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17.04. | Treace Medical Concepts, Inc.: Treace to Present at Bank of America Health Care Conference | 1 | GlobeNewswire (USA) | ||
| 16.04. | Treace Medical Concepts, Inc.: Treace Announces First Annual National Bunion Day | 1 | GlobeNewswire (USA) | ||
| 09.04. | Treace Medical Concepts, Inc.: Treace to Report First Quarter 2024 Financial Results | 1 | GlobeNewswire (USA) | ||
| 05.03. | Earnings call: Treace Medical Concepts reports 32% revenue rise in 2023 | 1 | Investing.com | ||
| 28.02. | Treace Medical Concepts Inc reports results for the quarter ended in December - Earnings Summary | 2 | Reuters | ||
| 27.02. | Recap: Treace Medical Concepts Q4 Earnings | 1 | Benzinga.com | ||
| 27.02. | TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 27.02. | Treace Medical Concepts, Inc.: Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance | 165 | GlobeNewswire (Europe) | PONTE VEDRA, Fla., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
| 26.02. | Earnings Preview For Treace Medical Concepts | 1 | Benzinga.com | ||
| 07.02. | Treace Medical Concepts, Inc.: Treace to Report Fourth Quarter and Full-Year 2023 Financial Results | 1 | GlobeNewswire (USA) | ||
| 02.02. | Treace Medical Concepts, Inc.: Treace Announces Interim 3-Year ALIGN3D Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure | 2 | GlobeNewswire (USA) | ||
| 01.02. | Treace Medical Concepts, Inc.: Treace to Highlight Latest Product Innovations and ALIGN3D Study Outcomes at the 2024 ACFAS Annual Scientific Conference | 1 | GlobeNewswire (USA) | ||
| 08.01. | Treace Medical forecasts upbeat Q4, 2023 revenue outlook | 2 | Seeking Alpha | ||
| 08.01. | Treace Medical Concepts rises on preliminary Q4 revenue beat | 2 | Reuters | ||
| 08.01. | TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 08.01. | Treace Medical Concepts, Inc.: Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue | 262 | GlobeNewswire (Europe) | PONTE VEDRA, Fla., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
| 22.12.23 | 6 Analysts Assess Treace Medical Concepts: What You Need To Know | 2 | Benzinga.com | ||
| 19.12.23 | Treace Medical Concepts, Inc.: Treace to Present at 42nd Annual J.P. Morgan Healthcare Conference | 2 | GlobeNewswire (USA) | ||
| 07.12.23 | Does the New Anti-Obesity Medicine Affect Treace Medical Concepts (TMCI)? | 1 | Insider Monkey | ||
| 12.11.23 | Treace Medical Concepts, Inc. (TMCI) Q3 2023 Earnings Call Transcript | 2 | Insider Monkey |
Seite:
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ORPEA | 13,436 | +0,60 % | ORPEA: emeis Sells a Real-Estate Portfolio in the Netherlands Worth a Total Value of Around €97 Million | Regulatory News:
ORPEA (Paris:ORP):
emeis announces that it has signed an agreement to sell a real estate portfolio of eleven nursing homes in the Netherlands to Bouwinvest for a total deed-in-hand... ► Artikel lesen | |
| NANO-X IMAGING | 9,345 | +1,14 % | Nano-X Imaging LTD.: Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold | - According to early findings in the ADOPT study, Nanox.AI software improves detection of key risk factor for osteoporosis, outperforming UK National Health Service national average - Findings... ► Artikel lesen | |
| BUTTERFLY NETWORK | 0,945 | +2,78 % | Butterfly Network Reports First Quarter 2024 Financial Results | BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with handheld, whole-body ultrasound... ► Artikel lesen | |
| GOODRX | 7,110 | +1,43 % | GoodRx Reports Fourth Quarter and Full Year 2023 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., has released its financial... ► Artikel lesen | |
| JOINT CORP | 16,120 | +25,35 % | Joint Corp reports results for the quarter ended in March - Earnings Summary | ||
| CARMAT | 3,090 | +0,49 % | CARMAT: Availability of the 2023 Universal Registration Document | Regulatory News:
CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from... ► Artikel lesen | |
| HYPERFINE | 0,800 | +1,70 % | Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | GUILFORD, Conn., March 21, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
| PROGYNY | 31,710 | -1,12 % | Progyny, Inc. Announces Third Quarter 2023 Results | Record Quarterly Revenue of $280.9 Million, Reflecting 37% Growth Over the Prior Year PeriodRaises Full Year Revenue and Earnings GuidanceStrong Sales Season Produces 1.3 Million New Covered Lives... ► Artikel lesen | |
| MIMEDX | 7,370 | -1,73 % | MiMedx Group, Inc: MIMEDX Announces First Quarter 2024 Operating and Financial Results | Net Sales of $85 Million Grew 18% Year-Over-Year for the First Quarter First Quarter GAAP Net Income was $9 Million First Quarter Adjusted EBITDA of $19 Million, or 22% of Net Sales Management... ► Artikel lesen | |
| BIOMERICA | 0,560 | -6,67 % | Biomerica jumps on signing multi-year distribution deal with major UAE healthcare company | ||
| ATRION | 384,00 | -3,03 % | Dividendenbekanntmachungen (14.03.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN PLC GB00BF8Q6K64 0,073 GBP 0,0853 EUR ABRDN PLC ADR US00108N1000 0,3203 USD 0,2925 EUR ACCO BRANDS CORPORATION US00081T1088 0... ► Artikel lesen | |
| ATRICURE | 20,890 | -5,99 % | AtriCure Reports First Quarter 2024 Financial Results | MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and... ► Artikel lesen | |
| TALKSPACE | 3,170 | +1,28 % | Talkspace to Report First Quarter 2024 and Host Conference Call | ||
| AMWELL | 0,573 | +10,17 % | American Well Corp reports results for the quarter ended in January - Earnings Summary | ||
| CASTLE BIOSCIENCES | 24,330 | +6,52 % | Castle Biosciences Reports First Quarter 2024 Results | FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results... ► Artikel lesen |
TREACE MEDICAL CONCEPTS INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +2,71 % bei einem Aktienkurs von 11,000 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
